World's Best Scientists 2026 revealed!
VIEW LIST
Alfredo Falcone

Alfredo Falcone

University of Pisa
Italy

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 95 9896 9284 349 334 1122 45015

Alfredo Falcone publications per year

The chart shows the history of publications by Alfredo Falcone between 1986 and 2026, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Alfredo Falcone published across 41 years, from 1986 to 2026, averaging 29.6 papers a year. Output peaked at 87 publications in 2017. 3 of the 1,212 publications appeared in the last two years.

No. of publications
20 40 60 80
Bar chart. Horizontal axis: year, 1986 to 2026. Vertical axis: number of publications, 0 to 87. Peak 87 publications in 2017. 1986: 2 publications 1987: 6 publications 1988: 4 publications 1989: 4 publications 1990: 5 publications 1991: 5 publications 1992: 1 publication 1993: 4 publications 1994: 12 publications 1995: 9 publications 1996: 7 publications 1997: 4 publications 1998: 4 publications 1999: 9 publications 2000: 5 publications 2001: 10 publications 2002: 6 publications 2003: 12 publications 2004: 11 publications 2005: 9 publications 2006: 35 publications 2007: 45 publications 2008: 56 publications 2009: 62 publications 2010: 49 publications 2011: 36 publications 2012: 81 publications 2013: 49 publications 2014: 57 publications 2015: 85 publications 2016: 84 publications 2017: 87 publications 2018: 82 publications 2019: 82 publications 2020: 61 publications 2021: 41 publications 2022: 12 publications 2023: 73 publications 2024: 3 publications 2025: 2 publications 2026: 1 publication
1986 2026

1,212 publications in total across all disciplines

View publications per year as a table
Alfredo Falcone: publications per year, 1986 to 2026
Year Publications
1986 2
1987 6
1988 4
1989 4
1990 5
1991 5
1992 1
1993 4
1994 12
1995 9
1996 7
1997 4
1998 4
1999 9
2000 5
2001 10
2002 6
2003 12
2004 11
2005 9
2006 35
2007 45
2008 56
2009 62
2010 49
2011 36
2012 81
2013 49
2014 57
2015 85
2016 84
2017 87
2018 82
2019 82
2020 61
2021 41
2022 12
2023 73
2024 3
2025 2
2026 1
Total 1,212
Download as CSV

Alfredo Falcone publications per year - data summary

  • Alfredo Falcone, a Medicine scholar from University of Pisa, has 1,212 publications recorded across 41 years, from 1986 to 2026.
  • The oldest publication on record dates to 1986 and the most recent to 2026.
  • The most productive year is 2017, with 87 publications.
  • The least productive years with any output are 1992 and 2026, with 1 publication each.
  • The rate of publication averages 29.6 papers per year over the whole span, or 29.6 per year counting only the 41 years with at least one publication.
  • The last 5 years on the chart (2022-2026) hold 91 publications, 8% of the career total.
  • Split into equal eras - 1986-1999: 76 publications (5.4 per year); 2000-2013: 466 publications (33.3 per year); 2014-2026: 670 publications (51.5 per year).
  • Comparing the opening and closing eras, the overall trend of publication is rising.

Alfredo Falcone publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Alfredo Falcone sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 1,121–1,140 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 1,122 publications — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49 1,122
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Alfredo Falcone publication distribution in Medicine in 2026 - data summary

  • The chart plots the publication count of all 20,134 Medicine scientists ranked by Research.com in 2026, grouped into 86 ranges running from 101–120 to 1,796+ publications.
  • Alfredo Falcone, a Medicine scholar from University of Pisa, records 1,122 publications - the 96th percentile of the discipline.
  • 96% of ranked Medicine scientists score the same or lower than Alfredo Falcone, and about 4% score higher.
  • The median of the discipline falls in the 441–460 publications range, and Alfredo Falcone ranks above the median.
  • The most crowded range is 341–360 publications, holding 922 scientists (5% of the field).
  • 64% of the field sits in the lowest quarter of the value range (up to 521–540 publications), so the distribution is heavily right-skewed and high scores are rare.
  • The final bar has no upper bound: it groups every scientist with 1,796 publications or more, 100 scientists in all (<1% of the field).

Alfredo Falcone D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Alfredo Falcone sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 94–95 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 95 D-Index — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808 95
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Alfredo Falcone D-index placement in Medicine in 2026 - data summary

  • The chart plots the discipline H-index (D-index) of all 20,134 Medicine scientists ranked by Research.com in 2026, grouped into 75 ranges running from 70–71 to 217+ D-Index.
  • Alfredo Falcone, a Medicine scholar from University of Pisa, records 95 D-Index - the 51st percentile of the discipline.
  • 51% of ranked Medicine scientists score the same or lower than Alfredo Falcone, and about 49% score higher.
  • The median of the discipline falls in the 94–95 D-Index range, and Alfredo Falcone falls inside that same range.
  • The most crowded range is 82–83 D-Index, holding 1,027 scientists (5% of the field).
  • 70% of the field sits in the lowest quarter of the value range (up to 106–107 D-Index), so the distribution is heavily right-skewed and high scores are rare.
  • The final bar has no upper bound: it groups every scientist with 217 D-Index or more, 98 scientists in all (<1% of the field).

Overview

Alfredo Falcone is affiliated with the University of Pisa in Italy, specializing in medical research with a focus on oncology. Their work encompasses a broad range of studies on cancer treatment and related fields.

Falcone's research primarily focuses on the following topics:

  • Colorectal Cancer Treatments and Studies
  • Genetic factors in colorectal cancer
  • Cancer Genomics and Diagnostics
  • Cancer Treatment and Pharmacology
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Gastric Cancer Management and Outcomes
  • Cancer Immunotherapy and Biomarkers

Their contributions span across several subfields of study within medicine, including:

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research
  • Pathology and Forensic Medicine
  • Hepatology

Alfredo Falcone has co-authored extensively with several researchers, indicating collaborative work within the oncology community. Frequent coauthors include:

  • Chiara Cremolini
  • Daniele Rossini
  • Heinz-Josef Lenz
  • Carlotta Antoniotti
  • Gianluca Masi

The primary venues for Falcone's research publications are journals focused on clinical oncology and cancer research, which include:

  • Journal of Clinical Oncology
  • Annals of Oncology
  • European Journal of Cancer
  • Cancers
  • ESMO Open

Some of the recent publications authored or coauthored by Alfredo Falcone are:

  • Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial, 2023, The Lancet
  • Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial, 2020, The Lancet Oncology
  • Individual Patient Data Meta-Analysis of FOLFOXIRI Plus Bevacizumab Versus Doublets Plus Bevacizumab as Initial Therapy of Unresectable Metastatic Colorectal Cancer, 2020, Journal of Clinical Oncology
  • Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma, 2024, Annals of Oncology
  • Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment, 2022, ESMO Open

Alfredo Falcone's published research outputs contribute to the understanding and treatment of advanced and metastatic cancers, including colorectal cancer and hepatocellular carcinoma, with a clinical focus spanning immunotherapies, combination chemotherapies, and lung disease related to cancer treatments.

Best Publications

  • ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

    E. Van Cutsem;A. Cervantes;R. Adam;A. Sobrero

  • Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial

    Axel Grothey;Eric Van Cutsem;Alberto Sobrero;Salvatore Siena

  • Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer: The Gruppo Oncologico Nord Ovest

    Alfredo Falcone;Sergio Ricci;Isa Brunetti;Elisabetta Pfanner

  • Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer

    Robert J Mayer;Eric Van Cutsem;Alfredo Falcone;Takayuki Yoshino

  • Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

    Kohei Shitara;Mustafa Özgüroğlu;Yung-Jue Bang;Maria Di Bartolomeo

  • FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study

    Chiara Cremolini;Fotios Loupakis;Carlotta Antoniotti;Cristiana Lupi

  • Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer

    Fotios Loupakis;Chiara Cremolini;Gianluca Masi;Sara Lonardi

  • Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients

    Giulia Siravegna;Benedetta Mussolin;Michela Buscarino;Giorgio Corti

  • KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer

    F Loupakis;A Ruzzo;C Cremolini;B Vincenzi

  • Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

    Miguel Martin;Frankie A Holmes;Bent Ejlertsen;Suzette Delaloge

  • Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database

    Jan Franko;Qian Shi;Jeffrey P Meyers;Timothy S Maughan

  • MicroRNA-21 in Pancreatic Cancer: Correlation with Clinical Outcome and Pharmacologic Aspects Underlying Its Role in the Modulation of Gemcitabine Activity

    Elisa Giovannetti;Niccola Funel;Godefridus J. Peters;Marco Del Chiaro

  • Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial

    Cathy Eng;Tae Won Kim;Johanna Bendell;Guillem Argilés

  • PTEN Expression and KRAS Mutations on Primary Tumors and Metastases in the Prediction of Benefit From Cetuximab Plus Irinotecan for Patients With Metastatic Colorectal Cancer

    Fotios Loupakis;Luca Pollina;Irene Stasi;Annamaria Ruzzo

  • Primary Tumor Location as a Prognostic Factor in Metastatic Colorectal Cancer

    Fotios Loupakis;Dongyun Yang;Linda Yau;Shibao Feng

  • Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial

    Josep Tabernero;Heinz Josef Lenz;Salvatore Siena;Alberto Sobrero

  • Quantitative evidence for early metastatic seeding in colorectal cancer.

    Zheng Hu;Jie Ding;Zhicheng Ma;Ruping Sun

  • Pharmacogenetic Profiling in Patients With Advanced Colorectal Cancer Treated With First-Line FOLFOX-4 Chemotherapy

    Annamaria Ruzzo;Francesco Graziano;Fotios Loupakis;Eliana Rulli

  • Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan: A Phase 2 Single-Arm Clinical Trial.

    Chiara Cremolini;Daniele Rossini;Emanuela Dell’Aquila;Sara Lonardi

  • KRAS codon 61, 146 and BRAF V600E mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer

    A. Ruzzo;F. Loupakis;E. Canestrari;Chiara Cremolini

Frequent Co-Authors

Fotios Loupakis
Fotios Loupakis Istituto Oncologico Veneto
Sara Lonardi
Sara Lonardi Istituto Oncologico Veneto
Romano Danesi
Romano Danesi University of Pisa
Daniele Santini
Daniele Santini Università Campus Bio-Medico
Heinz-Josef Lenz
Heinz-Josef Lenz University of Southern California
Gabriella Fontanini
Gabriella Fontanini University of Pisa
Stefano Cascinu
Stefano Cascinu Vita-Salute San Raffaele University
Giuseppe Tonini
Giuseppe Tonini Università Campus Bio-Medico
Bruno Vincenzi
Bruno Vincenzi Università Campus Bio-Medico
Pierfranco Conte
Pierfranco Conte University of Padua

External Links

Personal website of Alfredo Falcone

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative career options and degrees in healthcare can open many exciting doors beyond traditional medical school. One in-demand field is medical billing and coding schools online, which offer flexible programs for those interested in the administrative side of healthcare, with financial aid often available.

For those drawn to patient care, nursing is a rewarding path with several accessible options. If you want a faster route and fewer testing barriers, consider a nursing school that don't require teas—these programs waive common entrance exams, allowing you to focus on your studies.

If healthcare leadership interests you, pursuing healthcare administration degrees can lead to roles in hospital or clinic management, with many accelerated online options catering to busy professionals.

Current RNs looking to advance their careers may benefit from rn to np bridge programs. These pathways help nurses earn advanced practice credentials more efficiently, expanding their scope of practice and earning potential.

Best Scientists Citing Alfredo Falcone

Josep Tabernero

Josep Tabernero

Vall d´Hebron Institute of Oncology

Publications: 113

Heinz-Josef Lenz

Heinz-Josef Lenz

University of Southern California

Publications: 105

Elisa Giovannetti

Elisa Giovannetti

VU University Medical Center

Publications: 100

David Cunningham

David Cunningham

Royal Marsden NHS Foundation Trust

Publications: 83

Scott Kopetz

Scott Kopetz

The University of Texas MD Anderson Cancer Center

Publications: 79

Fortunato Ciardiello

Fortunato Ciardiello

University of Campania "Luigi Vanvitelli"

Publications: 79

Alberto Bardelli

Alberto Bardelli

University of Turin

Publications: 78

Volker Heinemann

Volker Heinemann

Ludwig-Maximilians-Universität München

Publications: 78

Eric Van Cutsem

Eric Van Cutsem

KU Leuven

Publications: 75

Salvatore Siena

Salvatore Siena

University of Milan

Publications: 74

Takayuki Yoshino

Takayuki Yoshino

University of Tsukuba

Publications: 68

Kei Muro

Kei Muro

National Cancer Research Institute, UK

Publications: 68

Axel Grothey

Axel Grothey

University of Tennessee at Knoxville

Publications: 65

Julien Taieb

Julien Taieb

Université Paris Cité

Publications: 64

Sara Lonardi

Sara Lonardi

Istituto Oncologico Veneto

Publications: 64

Stefano Cascinu

Stefano Cascinu

Vita-Salute San Raffaele University

Publications: 63

Trending Scientists

Stephan Link

Stephan Link

Rice University

Lin Guo

Lin Guo

Beihang University

Mark R. Thomas

Mark R. Thomas

Commonwealth Scientific and Industrial Research Organisation

Frazer J. Rixon

Frazer J. Rixon

University of Glasgow

Mark Hemer

Mark Hemer

CSIRO Marine and Atmospheric Research

Armando J. Parodi

Armando J. Parodi

Consejo Nacional de Investigaciones Científicas y Técnicas

Sandrine Silvente-Poirot

Sandrine Silvente-Poirot

Federal University of Toulouse Midi-Pyrénées

Peter Ruhdal Jensen

Peter Ruhdal Jensen

Technical University of Denmark

Olgeir Sigmarsson

Olgeir Sigmarsson

University of Iceland

Ryan D. Gold

Ryan D. Gold

United States Geological Survey

Marion Nestle

Marion Nestle

New York University

Thomas Webler

Thomas Webler

Keene State College

Luigi Chisci

Luigi Chisci

University of Florence

Taiji Suzuki

Taiji Suzuki

University of Tokyo

Mark Lunt

Mark Lunt

University of Manchester

Pierre Bedossa

Pierre Bedossa

Inserm

Related Medicine Rankings & Guides

2027 Best Online Exercise Science Degree Programs

2027 Best Online Exercise Science Degree Programs
2027 Most Affordable CNA to RN Online Bridge Programs

2027 Most Affordable CNA to RN Online Bridge Programs
2027 Best Nurse Practitioner Programs in Indiana – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Indiana – Accredited Schools Online & Campus
2027 Most Affordable Online AGNP Programs

2027 Most Affordable Online AGNP Programs
2027 Best Shortest Online PMHNP Certificate Programs

2027 Best Shortest Online PMHNP Certificate Programs
2027 Best Nurse Practitioner Programs in Arizona – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Arizona – Accredited Schools Online & Campus
2027 CMAA vs. CCMA Certification: Explaining the Difference

2027 CMAA vs. CCMA Certification: Explaining the Difference
2027 Easiest Radiology Programs to Get Into

2027 Easiest Radiology Programs to Get Into
2027 Best Online Surgical Tech Certificate Programs

2027 Best Online Surgical Tech Certificate Programs
2027 Best Online Pharmacy Technician Associate Programs

2027 Best Online Pharmacy Technician Associate Programs
2027 Best Nursing Schools in Minnesota – Accredited ADN, BSN, MSN Programs

2027 Best Nursing Schools in Minnesota – Accredited ADN, BSN, MSN Programs
2027 Best Online DNP Programs Without Clinicals

2027 Best Online DNP Programs Without Clinicals
2027 Best Nurse Practitioner Programs in Connecticut – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Connecticut – Accredited Schools Online & Campus
2027 Best Nurse Practitioner Programs in Wisconsin – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Wisconsin – Accredited Schools Online & Campus
2027 Healthcare Administration Degree Guide: Costs, Requirements & Job Opportunities

2027 Healthcare Administration Degree Guide: Costs, Requirements & Job Opportunities
2027 Most Affordable Online Certified Nursing Assistant (CNA) Programs

2027 Most Affordable Online Certified Nursing Assistant (CNA) Programs
2027 Best Online Sonography Programs

2027 Best Online Sonography Programs
2027 Best Shortest Online DNP Programs

2027 Best Shortest Online DNP Programs
2027 Most Affordable Online Health Information Management Degree Programs

2027 Most Affordable Online Health Information Management Degree Programs
2027 Best Online MSN in Health/Nursing Informatics Programs

2027 Best Online MSN in Health/Nursing Informatics Programs
2027 Best Online Master’s in Clinical Research Programs

2027 Best Online Master’s in Clinical Research Programs

Recently Published Articles

2027 MBA vs. Master's in Analytics: Which Drives Better Career Outcomes

2027 MBA vs. Master's in Analytics: Which Drives Better Career Outcomes
2027 Is Walden University's Online BSN to MSN - Dual MSN/MBA Degree Worth It? What Students Should Know

2027 Is Walden University's Online BSN to MSN - Dual MSN/MBA Degree Worth It? What Students Should Know
2027 How Long Does It Take to Earn an Online Organizational Leadership Degree?

2027 How Long Does It Take to Earn an Online Organizational Leadership Degree?
2027 Best Marriage and Family Therapy (MFT) Programs in Florida: Online & Campus

2027 Best Marriage and Family Therapy (MFT) Programs in Florida: Online & Campus
2027 Online Ph.D. Programs With No Dissertation: Specializations, Cost & Period of Study

2027 Online Ph.D. Programs With No Dissertation: Specializations, Cost & Period of Study
2027 Online SLP Master's Programs for Kansas Residents: Eligibility, Tuition, and Clinical Placements

2027 Online SLP Master's Programs for Kansas Residents: Eligibility, Tuition, and Clinical Placements
2027 Which Employers Hire Art History Degree Graduates? Industries, Roles, and Hiring Patterns

2027 Which Employers Hire Art History Degree Graduates? Industries, Roles, and Hiring Patterns
2027 Pros and Cons of Being a Medical Biller and Coder

2027 Pros and Cons of Being a Medical Biller and Coder
2027 How Long Does It Take to Earn an Online Sports Management Degree?

2027 How Long Does It Take to Earn an Online Sports Management Degree?
2027 LPC Counseling Licensure Requirements in Georgia

2027 LPC Counseling Licensure Requirements in Georgia
2027 What Can You Do with a Business Psychology Degree: Costs & Job Opportunities

2027 What Can You Do with a Business Psychology Degree: Costs & Job Opportunities
2027 What Do You Learn in a Radiology Technician Degree: Curriculum, Skills & Core Competencies

2027 What Do You Learn in a Radiology Technician Degree: Curriculum, Skills & Core Competencies
Best Direct-Entry MSN Programs in Pennsylvania: Online & Campus for 2027

Best Direct-Entry MSN Programs in Pennsylvania: Online & Campus for 2027
2027 Fastest Online Electrical Engineering Master's Degree Programs You Can Finish in Under 2 Years

2027 Fastest Online Electrical Engineering Master's Degree Programs You Can Finish in Under 2 Years
2027 Highest Paying Careers With an Entrepreneurship Bachelor's Degree

2027 Highest Paying Careers With an Entrepreneurship Bachelor's Degree
2027 Online Clinical Psychology Degree Programs for Veterans: GI Bill Benefits, Costs & Top Considerations

2027 Online Clinical Psychology Degree Programs for Veterans: GI Bill Benefits, Costs & Top Considerations
2027 Homeland Security Degree Completion Programs for Working Adults

2027 Homeland Security Degree Completion Programs for Working Adults
2027 Best Marriage and Family Therapy (MFT) Programs in North Carolina: Online & Campus

2027 Best Marriage and Family Therapy (MFT) Programs in North Carolina: Online & Campus
2027 Best Online Master's in Finance for Commercial Banking Careers

2027 Best Online Master's in Finance for Commercial Banking Careers
2027 Most Affordable Online Master's Degrees in Finance

2027 Most Affordable Online Master's Degrees in Finance
2027 How to Become a Criminal Psychologist in Utah

2027 How to Become a Criminal Psychologist in Utah